19F MRI of Ventilation in Subjects With Cystic Fibrosis Undergoing Treatment for Pulmonary Exacerbation
Status:
Terminated
Trial end date:
2019-09-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to use perfluorinated gas imaging to highlight regions of
functional variation within the lungs of participants with cystic fibrosis (CF), and to
correlate this with changes in spirometry, lung clearance index, and quality of life of CF
subjects undergoing treatment for a pulmonary exacerbation.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)